Bruxism is the involuntary, repetitive grinding or clenching of the teeth and jaw muscles, occurring during sleep (sleep bruxism) or wakefulness (awake bruxism). It involves hyperactivity of the masseter, temporalis, and medial pterygoid muscles driven by dysregulated central nervous system motor output, elevated sympathetic nervous system tone, and disrupted dopaminergic and serotonergic neurotransmitter signaling. Sleep bruxism is classified as a sleep-related movement disorder characterized by rhythmic masticatory muscle activity (RMMA) occurring in association with brief micro-arousals during non-REM and REM sleep transitions. The prevalence of sleep bruxism is estimated at approximately 8 to 13 percent of the adult population, with higher rates reported in children (approximately 14 to 20 percent) and individuals with elevated psychological stress loads. Awake bruxism affects approximately 22 to 31 percent of adults and is strongly associated with psychological arousal, anxiety, and attentional states.
The central neurobiology of bruxism involves dysregulation of the dopaminergic nigrostriatal pathway — dopamine modulates the rhythmic motor output of the trigeminal motor nucleus governing jaw muscle contraction; reduced dopaminergic tone or altered D1/D2 receptor signaling disinhibits the trigeminal motor nucleus, creating involuntary repetitive jaw muscle contractions; the serotonergic system also modulates bruxism — serotonin inhibits dopamine release in the basal ganglia, and disrupted serotonin/dopamine balance is a documented neurochemical correlate of sleep bruxism; the GABAergic system provides inhibitory tone to the trigeminal motor nucleus during sleep, and reduced GABA activity during sympathetic arousal-associated micro-arousals allows RMMA episodes to occur.
The musculoskeletal consequences of chronic bruxism include masseter muscle hypertrophy, myofascial trigger points in the masseter and temporalis, temporomandibular joint (TMJ) disc displacement and condylar remodeling, dental attrition (wear of enamel and dentin), tooth sensitivity, tooth fracture, and morning jaw pain and headache. Systemic associations include elevated cortisol, magnesium deficiency (magnesium regulates NMDA receptor-mediated neuromuscular activity and sympathetic nervous system tone), calcium-to-magnesium ratio imbalance affecting neuromuscular signaling, iron deficiency (associated with restless legs syndrome — sharing central dopaminergic dysregulation with bruxism), and B-vitamin deficiencies affecting neurotransmitter synthesis.
A whole food plant-based diet provides magnesium from leafy greens, seeds, and legumes targeting the neuromuscular excitability component; calcium from kale, broccoli, and fortified plant foods for neuromuscular signaling balance; tryptophan from whole plant sources as the serotonin/melatonin precursor targeting the serotonergic modulation of dopamine in bruxism; B vitamins from whole grains and legumes for dopamine and GABA synthesis; and anti-inflammatory polyphenols targeting the neuroinflammatory component of central sensitization in chronic bruxism.
Psychological stress and anxiety (most strongly associated modifiable factor); sleep disorders including obstructive sleep apnea (OSA) and sleep-disordered breathing; dopaminergic dysregulation (central nervous system dopamine imbalance); serotonergic dysregulation; elevated sympathetic nervous system tone; magnesium deficiency (neuromuscular excitability); calcium dysregulation; iron deficiency (shared dopaminergic mechanism with restless legs); B-vitamin deficiencies (B6, B1, B9 affecting neurotransmitter synthesis); chronic caffeine intake (sympathomimetic — increases sympathetic arousal); elevated cortisol (HPA axis dysregulation); malocclusion and dental occlusal factors (contributing but not primary cause); genetic predisposition (heritability estimated 50%); nicotine use; alcohol consumption; TMJ disc displacement; central sensitization from chronic myofascial pain.
Caffeine (sympathomimetic — increases sympathetic arousal and bruxism severity); alcohol (disrupts sleep architecture, increases sleep bruxism frequency during alcohol withdrawal phases of the sleep cycle); nicotine/tobacco (sympathomimetic — elevates catecholamine levels driving masseter hyperactivity); heavy metals including mercury (neurotoxic — affects dopaminergic and GABAergic neurotransmission); lead (neurotoxic — disrupts dopamine synthesis and NMDA receptor function); pesticide residues with neurotoxic properties affecting central dopamine balance; food additives including artificial dyes and preservatives (reported to increase hyperactivity and stress-related muscle tension); synthetic food colorings linked to dopaminergic disruption in sensitive individuals; high-sodium processed foods elevating cortisol and sympathetic tone; refined sugar driving blood glucose dysregulation and HPA axis activation.
Dopamine synthesis and turnover (nigrostriatal pathway — D1/D2 receptor modulation of trigeminal motor nucleus); serotonin/melatonin pathway (serotonin inhibits dopamine in basal ganglia; melatonin modulates sleep architecture and RMMA episodes); GABA/glutamate balance (GABAergic inhibition of trigeminal motor nucleus during sleep); HPA axis/cortisol pathway (stress-driven sympathetic activation triggering masseter hyperactivity); NMDA receptor/magnesium pathway (magnesium blocks NMDA receptor channels reducing neuromuscular hyperexcitability); norepinephrine/epinephrine pathway (sympathetic arousal driving RMMA micro-arousals); NF-kB neuroinflammation pathway (central sensitization in chronic bruxism); tryptophan-kynurenine pathway (tryptophan → 5-HTP → serotonin → melatonin); one-carbon/folate cycle (B9/B12 for dopamine synthesis support); transsulfuration pathway (cysteine → glutathione for oxidative stress from muscle hyperactivity); circadian rhythm regulation (disruption increases sleep bruxism frequency); AMPK signaling (energy sensing in overworked masseter muscle).
A whole food plant-based diet addresses bruxism through multiple converging nutritional mechanisms targeting the neuromuscular and neurochemical foundations of jaw hyperactivity. Magnesium-rich foods including spinach, pumpkin seeds, hemp seeds, black beans, quinoa, and amaranth directly reduce NMDA receptor-mediated neuromuscular excitability in the trigeminal motor nucleus. Tryptophan from quinoa, soybeans, pumpkin seeds, and sunflower seeds provides the precursor for serotonin and melatonin synthesis, supporting the serotonergic modulation of dopamine in the basal ganglia that underlies bruxism neurobiology. B-vitamin-rich whole foods — lentils and leafy greens for B9, sunflower seeds and chickpeas for B6, whole grains for B1 and B3 — supply the cofactors for dopamine, serotonin, and GABA synthesis. Iron from lentils, chickpeas, and pumpkin seeds supports tyrosine hydroxylase-dependent dopamine production. Anti-inflammatory polyphenols from berries, turmeric, and green tea reduce neuroinflammatory NF-kB signaling contributing to central sensitization in chronic bruxism.
Magnesium from spinach, pumpkin seeds, hemp seeds, black beans, quinoa, and amaranth is the most directly relevant mineral to bruxism neurobiology — magnesium functions as a voltage-dependent blocker of NMDA receptor Ca2+ ion channels in the trigeminal motor nucleus; hypomagnesemia removes this block, increasing glutamate-driven neuromuscular excitability driving masseter and temporalis hyperactivity; published research confirms magnesium supplementation reduced sleep bruxism frequency and morning jaw pain in deficient individuals; magnesium additionally modulates parasympathetic tone by reducing catecholamine secretion from the adrenal medulla, directly decreasing sympathetic arousal-driven RMMA micro-arousal frequency. Tryptophan from quinoa, soybeans, edamame, pumpkin seeds, and sunflower seeds is the dietary precursor for serotonin (5-HT) synthesis — serotonin inhibits dopamine release in the striatum through 5-HT2C receptor activation, normalizing the dopaminergic tone in the nigrostriatal pathway that modulates trigeminal motor nucleus output; tryptophan is also the precursor for melatonin, which promotes sleep architecture stability reducing sympathetic micro-arousal frequency that triggers RMMA episodes; published research confirms the tryptophan → serotonin → melatonin pathway as relevant to sleep bruxism reduction. Vitamin B6 from sunflower seeds, chickpeas, bananas, and potatoes is the essential cofactor for aromatic L-amino acid decarboxylase (AADC) converting 5-hydroxytryptophan (5-HTP) to serotonin and L-DOPA to dopamine — B6 deficiency specifically impairs serotonin and dopamine synthesis at the AADC step, compounding the dopaminergic and serotonergic dysregulation underlying bruxism. Iron from lentils, chickpeas, spinach, pumpkin seeds, and soybeans supports tyrosine hydroxylase (TH) — the iron-dependent, rate-limiting enzyme in catecholamine biosynthesis converting tyrosine to L-DOPA (the immediate dopamine precursor); iron deficiency reduces TH activity, lowering dopamine production and creating the dopaminergic insufficiency pattern shared with restless legs syndrome and sleep bruxism. Quercetin from yellow onions, kale, and apples inhibits NF-kB neuroinflammatory signaling targeting central sensitization in chronic bruxism. Curcumin from turmeric inhibits NF-kB and COX-2, reducing neuroinflammatory prostaglandin production in sensitized trigeminal pathways. EGCG from green tea provides L-theanine (the calming amino acid reducing cortisol and promoting GABA activity) and antioxidant catechins reducing oxidative stress in overworked masseter muscle tissue. Calcium from kale, broccoli, bok choy, and fortified plant foods normalizes the calcium-magnesium ratio for balanced neuromuscular signaling — calcium is required for acetylcholine vesicle release at the neuromuscular junction while magnesium modulates the sensitivity of this process.
Nutritional focus in bruxism targets magnesium repletion for NMDA receptor neuromuscular regulation from spinach, pumpkin seeds, hemp seeds, black beans, quinoa, and amaranth; tryptophan for serotonin and melatonin synthesis from quinoa, soybeans, pumpkin seeds, and sunflower seeds; B6 from sunflower seeds and chickpeas as the AADC cofactor for serotonin and dopamine synthesis; iron from lentils, chickpeas, and pumpkin seeds for tyrosine hydroxylase-dependent dopamine production; B9 from lentils and leafy greens for dopamine and neurotransmitter methylation support; calcium from kale and broccoli for neuromuscular signaling balance; quercetin from yellow onions and kale for NF-kB neuroinflammation reduction; curcumin from turmeric for COX-2/NF-kB anti-inflammatory activity targeting central sensitization; L-theanine from green tea for GABA tone and cortisol reduction; B1 from whole grains and legumes for nervous system energy metabolism; B3 from whole grains for NAD+ and dopamine pathway co-factor support; potassium from bananas, sweet potatoes, and lentils for electrolyte balance supporting neuromuscular function; selenium from brazil nuts and sunflower seeds for antioxidant defense in masseter oxidative stress; zinc from pumpkin seeds and legumes for GABA receptor modulation and neurotransmitter synthesis.
Spinach, Pumpkin Seeds, Hemp Seeds, Black Beans, Quinoa, Amaranth, Sunflower Seeds, Lentils, Chickpeas, Soybeans, Edamame, Kale, Broccoli, Bok Choy, Sweet Potato, Banana, Yellow Onion, Garlic, Celery, Fennel, Artichoke, Leek, Swiss Chard, Collard Greens, Mustard Greens, Brussels Sprouts, Watercress, Dandelion Greens, Broccolini, Scallions, Asparagus, Green Peas, Oats, Brown Rice, Wild Rice, Black Rice, Red Rice, Teff, Millet, Sorghum, Kamut, Spelt, Einkorn, Freekeh, Buckwheat Groats, Rye Berries, Purple Barley, Walnut, Almond, Brazil Nut, Pistachio, Pecan, Cashew, Hazelnut, Sesame Seeds, Chia Seeds, Flax Seeds, Cumin Seeds, Fennel Seeds, Fenugreek Seeds, Shiitake, Maitake, Lions Mane, Cremini, Portobello, Oyster Mushroom, Enoki, Maitake, King Oyster, Blueberry, Raspberry, Pomegranate, Cherry, Banana, Kiwi, Orange, Lemon, Avocado, Prune, Acai, Elderberry, Blackberry, Cranberry, Mung Beans, Split Peas, Black-eyed Peas, Adzuki Beans, Lupini Beans, Fava Beans, Pigeon Peas, Navy Beans, Kidney Beans, Green Tea, Turmeric, Ginger, Black Pepper, Garlic Powder, Parsley, Rosemary, Oregano, Thyme, Sage, Basil, Cilantro, Dill, Chives, Bay Leaf, Lemongrass, Cinnamon, Cloves, Saffron, Sumac, Paprika, Cayenne
magnesium,calcium,iron,zinc,selenium,potassium,vitamin-b6,vitamin-b1,vitamin-b2,vitamin-b3,vitamin-b5,vitamin-b9,vitamin-c,vitamin-e,vitamin-k1,vitamin-a,tryptophan,tyrosine,glycine,glutamine,quercetin,curcumin,egcg,l-theanine,rosmarinic-acid,caffeic-acid,chlorogenic-acid,apigenin,luteolin,6-gingerol,allicin,linalool,carvacrol,eugenol
Lobbezoo F, Ahlberg J, Raphael KG, et al. International consensus on the assessment of bruxism: Report of a work in progress. J Oral Rehabil. 2018;45(11):837-844.
PubMed PMID: 30054015.
Murali RV, Rangarajan P, Mounissamy A. Bruxism: Conceptual discussion and review. J Pharm Bioallied Sci. 2015;7(Suppl 1):S265-S270.
PMC4606594.
Oporto GH, Bornhardt T, Iturriaga V, Biedma BM. Neurobiology and neuropharmacology of bruxism. Med Oral Patol Oral Cir Bucal. 2013;18(6):e948-e952.
PMC3854062.
De Luca Canto G, Singh V, Gozal D, et al. Sleep bruxism and sleep-disordered breathing: A systematic review. J Oral Facial Pain Headache. 2014;28(4):299-305.
PubMed PMID: 25320903.
Falisi G, Rastelli C, Panti F, Maglione H, Quezada Arcega R. Psychotropic drugs and bruxism. Expert Opin Drug Saf. 2014;13(10):1319-1326.
PubMed PMID: 25180899.
Ohayon MM, Li KK, Guilleminault C. Risk factors for sleep bruxism in the general population. Chest. 2001;119(1):53-61.
PubMed PMID: 11157584.
Dubé C, Rompré PH, Manzini C, Guitard F, de Grandmont P, Lavigne GJ. Quantitative polygraphic controlled study on efficacy and safety of oral splint devices in tooth-grinding subjects. J Dent Res. 2004;83(5):398-403.
PubMed PMID: 15111630.
Ahlberg J, Lobbezoo F, Ahlberg K, et al. Self-reported bruxism mirrors anxiety and stress in adults. Med Oral Patol Oral Cir Bucal. 2013;18(1):e7-e11.
PMC3548637.
Bosman J, Roelofs A, de Laat A. The role of anxiety and muscle hyperactivity in bruxism. J Oral Rehabil. 2004;31(2):111-117.
PubMed PMID: 15009429.
Kuhn M, Türp JC. Risk factors for bruxism. Swiss Dent J. 2018;128(2):118-124.
PubMed PMID: 29533037.
Magnesium and neuromuscular hyperexcitability research: Serefko A, Szopa A, Poleszak E. Magnesium in depression. Pharmacol Rep. 2016;68(2):269-276.
PMC4549840.
These are not all research documents associated with this ailment or condition, as the volume of available studies is extensive and cannot be fully listed here. The data presented is derived directly from published research studies and primary scientific literature. All findings, observations, and conclusions reflect the content of the original studies and are attributed to the respective authors and researchers.
These are not all research documents associated with this ailment or condition, as the volume of available studies is extensive and cannot be fully listed here. The data presented is derived directly from published research studies and primary scientific literature. All findings, observations, and conclusions reflect the content of the original studies and are attributed to the respective authors and researchers.
